AMWL American Well Corporation
Healthcare$8.48+6.53%ClosedMarket Cap: $141.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.58
P/S
0.56
EV/EBITDA
0.78
DCF Value
$-84.45
FCF Yield
-31.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
49.7%
Operating Margin
-37.0%
Net Margin
-37.0%
ROE
-35.1%
ROA
-27.0%
ROIC
-35.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $54.9M | 37.2% | $-12.9M | $-10.9M | $— | — |
| Q4 null | $55.3M | 51.2% | $-25.2M | $-24.9M | $— | — |
| FY null | $249.3M | 53.3% | $-105.3M | $-95.7M | $— | — |
| Q3 null | $56.3M | 52.4% | $-29.3M | $-32.4M | $— | — |
| Q2 null | $70.9M | 56.1% | $-20.4M | $-19.7M | $— | — |
| Q1 null | $66.8M | 52.8% | $-30.4M | $-18.7M | $— | — |
| Q4 null | $71.0M | 48.4% | $-42.8M | $-42.7M | $— | — |
| FY null | $254.4M | 38.9% | $-217.5M | $-208.1M | $— | — |
| Q3 null | $61.0M | 37.2% | $-47.4M | $-43.5M | $— | — |
| Q2 null | $62.8M | 37.4% | $-52.4M | $-49.9M | $— | — |
| Q1 null | $59.5M | 30.9% | $-75.0M | $-72.1M | $— | — |
| Q4 2023 | $70.7M | 33.7% | $-57.0M | $-48.6M | $-3.37 | — |